1879.80
-0.29%
ICICI Securities Limited
Metropolis Healthcare’s (Metropolis) reported Q3FY23 performance was a mixed bag. Revenue declined 2.6% YoY (-5% QoQ) at Rs2.9bn (I-Sec: Rs2.8bn). Excluding Hi-Tech and government contract revenues, non-covid revenue grew ~13% YoY (+1,000bps from volume growth and +300bps from higher realisations).
Number of FII/FPI investors decreased from 194 to 173 in Mar 2025 qtr
More from Metropolis Healthcare Ltd.
Recommended